首页> 外文期刊>Indian journal of Anaesthesia >Hydrocortisone, Vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery
【24h】

Hydrocortisone, Vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery

机译:氢化可的松,维生素C和硫胺素治疗心脏手术后的败血症和脓毒性休克

获取原文
       

摘要

Background and Aims: The effect of vitamin C on vasopressor requirement in critically ill patients have been evaluated previously. We aimed to evaluate the effect of vitamin C, hydrocortisone and thiamine on vasopressor requirement and mortality in post-operative adult cardiac surgical patients with septic shock. Methods: About 24 patients with septic shock were randomised into Group 1 (receiving matching placebo per day for 4 days) and Group 2 (receiving 6 g vitamin C, 400 mg thiamine and 200 mg hydrocortisone per day for 4 days). Vasopressor dose over 4 days of therapy was the primary endpoint, whereas in-hospital mortality was the secondary endpoint. Results: APACHE IV and EUROSCORE II scores were similar between both the groups. Significant reductions in the requirement of vasopressin (difference from day 1 – 0.0008 ± 0.00289 vs 0.0033 ± 0.00492 units/kg/min; P = 0.019) and noradrenaline (difference from day 1 – 0.0283 ± 0.040 vs 0.023 ± 0.035 μg/kg/min; P = 0.006) were observed with vitamin C treatment as compared to control group. PCT levels on Day 3 (68.11 ± 33.64 vs 33.2 ± 27.55 ng/mL; P = 0.0161) and Day 4 (70.03 ± 29.74 vs 26.3 ± 23.08 ng/mL; P = 0.0009) were significantly lower in treatment group as compared to control. However, there was no difference in the Sepsis-Related Organ Failure Assessment (SOFA) score and mortality between the studied groups. Conclusion: Combination of vitamin C, thiamine and hydrocortisone reduces vasopressor requirement in adult cardiac surgical patients with septic shock.
机译:背景与目的:先前已经评估了维生素C对重症患者升压药物需求的影响。我们旨在评估维生素C,氢化可的松和硫胺素对患有败血性休克的成人心脏手术后患者的血管加压药需求和死亡率的影响。方法:将约24名败血症性休克患者随机分为1组(每天接受匹配的安慰剂4天)和2组(每天接受6 g维生素C,400 mg硫胺素和200 mg氢化可的松4天)。主要的研究终点是治疗4天的升压药剂量,而次要的终点指标是院内死亡率。结果:两组之间的APACHE IV和EUROSCORE II得分相似。降压素的需求量(第1天的差异– 0.0008±0.00289 vs 0.0033±0.00492单位/ kg / min; P = 0.019)和去甲肾上腺素(第1天的差异– 0.0283±0.040 vs 0.023±0.035μg/ kg / min ; P = 0.006)与对照组相比,维生素C处理观察到。与对照组相比,治疗组第3天的PCT水平(68.11±33.64 vs 33.2±27.55 ng / mL; P = 0.0161)和第4天(70.03±29.74 vs 26.3±23.08 ng / mL; P = 0.0009)与对照组相比明显降低。 。但是,研究组之间败血症相关器官衰竭评估(SOFA)评分和死亡率没有差异。结论:维生素C,硫胺素和氢化可的松的组合降低了败血性休克成年心脏手术患者的升压药需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号